Technical Advantages

Kangping Bio has consistently prioritized technological innovation as the cornerstone of its sustainable development strategy, steadily increasing R&D investment and building a technological innovation system. Its dedicated in-house R&D team possesses deep domain expertise in the bovine colostrum sector—systematically monitoring technological trends and market needs to drive evidence-based process optimization and product iteration. To strengthen its innovation capacity, Kangping Bio collaborates with leading academic and research institutions—appointing distinguished experts and scholars as long-term scientific advisors and co-founding industry–university joint innovation platforms with multiple domestic universities. Leveraging this mature innovation model, Kangping Bio has achieved multiple technological breakthroughs across four core domains: (1) extraction of functional bioactive components from bovine colostrum, (2) manufacturing process innovation, (3) proprietary equipment development, and (4) application-oriented product innovation. To date, the company holds 17 authorized technical patents, establishing a technological barrier.

Deeply committed to technological innovation and digital transformation, Kangping Bio has consistently enhanced its comprehensive capabilities and industry standing. To date, the company has been recognized with multiple authoritative certifications and honors at the national, provincial, and municipal levels—including designation as “National High-Tech Enterprise” and “SRDI (Specialized, Refined, Distinctive, and Innovative) SME”; approval as both Provincial and Municipal “Enterprise Technology Center”; recognition as “Heilongjiang Provincial Science Popularization Demonstration Base” and “Heilongjiang Provincial Digital (Intelligent) Demonstration Workshop”; and certified under the “Integration of Informatization and Industrialization Management System”—constructing a research and innovation system that integrates technological and process innovation, product R&D, digital integration, and science popularization.

Kangping Bio consistently strengthens its investment in technological innovation and has established research-production collaboration platforms with multiple universities in China. Focusing on specific technical bottlenecks and process upgrading needs, the company undertakes sustained, target-driven R&D initiatives, advancing product iteration and technological upgrading.

In the extraction of core bioactive components, Kangping Bio maintains collaborations with research teams from multiple universities, jointly developing novel extraction technologies and preparation processes for high-end functional ingredients—including lactoferrin (LF), epidermal growth factor (EGF), proline-rich polypeptides (PRPs), and hydrolyzed colostrum peptides.

At the product application and efficacy research level, Kangping Bio partners with authoritative medical institutions and universities, focusing on exploring the clinical value of core products such as bovine colostrum powder and hydrolyzed colostrum peptides.

As a recognized benchmark enterprise in China’s bovine colostrum industry, Kangping Bio serves as the lead drafting entity and principal contributor to multiple core industry standards and group standards. Leveraging its mature production technology, rigorous quality management system, and specialized industry expertise, the company has developed evidence-based, technically robust, and operationally implementable frameworks for production management and quality assurance across the sector. Thereby standardizing industrial practices, enhancing regulatory compliance, and advancing the sector toward healthy, orderly, and sustainable development.

Industry standards that Kangping Bio has contributed to include the light industry standard QB/T 5804 (Skimmed Colostrum Powder). This standard establishes comprehensive technical requirements for skimmed bovine colostrum powder, covering raw material specifications, manufacturing process controls, analytical testing methodologies, finished product quality criteria, and storage and transportation conditions—thereby serving as the authoritative regulatory and technical foundation for standardized production, quality assurance, and market circulation of bovine colostrum powder products in China.

Kangping Bio has participated in the formulation of multiple group standards, including T/WXYYXH 001 (Freeze-Dried Bovine Colostrum Powder), T/WXYYXH 002 (Freeze-Dried Colostrum Immunoglobulin Powder), and T/WXYYXH 003 (Bovine Colostrum-Derived Hydrolyzed Peptide Powder). These standards systematically refine safety requirements, manufacturing process controls, and analytical validation protocols across the spectrum of deep-processed bovine colostrum derivatives.